Balstilimab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Balstilimab
May 17, 2024, 11:18 |
Drugs
Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA
Agenus shared on LinkedIn: “Today we announced that Agenus has been granted a Type B…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 12, 2024, 03:08 |
Blog
CEO of Agenus, Garo Armen shares details on our royalty financing agreement with Ligand Pharmaceuticals
Agenus shared on LinkedIn: “‘With this infusion of capital, we are poised to accelerate the…
Apr 28, 2024, 05:36 |
Societies
Agenus selected for a poster presentation at the American Society of Clinical Oncology's ASCO2024 Annual Meeting
Quoting Agenus's post on LinkedIn: "Mark your calendars! We have been selected for a poster…
Apr 13, 2024, 06:43 |
Opinion
Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer
Agenus shared on LinkedIn: "Today we announced updated Phase 1 data and progress on our investigational…
Feb 21, 2024, 12:05 |
Insight
Pashtoon Kasi: See the discussion on our NEST-1trial by Rachna Shroff and Shaalan Beg
Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X/Twitter:…
Feb 14, 2024, 14:59 |
Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
Feb 14, 2024, 13:40 |
Insight
Karen Bedirian: Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: "Happy to share…
Jan 27, 2024, 15:39 |
Blog
Agenus joined oncology leaders from across the globe at ASCO GI (GI24)
Agenus recently posted on their LinkedIn page: "Agenus joined oncology leaders from across the globe…
Jan 20, 2024, 14:14 |
Drugs
Pashtoon Kasi: Are we on the verge of a new drug combo for colon or rectal cancer?
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X: "🆕🗞️Just…
1
2
All:
19
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube